Skip to main content
. 2022 Sep 29;13:998217. doi: 10.3389/fimmu.2022.998217

Figure 3.

Figure 3

(A) The number of publications, average citations of per items and H-index of the top 10 countries/regions. (B) Geographic distribution map displaying the global distribution of targeted immunotherapy for MG. Different countries/regions were denoted with different colors based on the number of articles published. (C) The annual number of publications from the top 10 countries/regions between 1998 and 2022. (D) Citation map of countries/regions on targeted immunotherapy for MG generated by the VOSviewer. Each node represents a country/region, and node size indicates the number of publications. The connection between the nodes represents a citation relationship, and the thickness of the lines indicates citation strength (weights on the TLS).